These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34708788)

  • 1. Outcomes of preoperative bevacizumab in diabetics with nonclearing vitreous hemorrhage without tractional detachment - A quasi-randomized retrospective study.
    Chakraborty D; Maiti A; Kelkar A; Sengupta S; Roy S; Bolisetty M; Kothari A; Majumder J
    Indian J Ophthalmol; 2021 Nov; 69(11):3283-3287. PubMed ID: 34708788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab.
    Hu X; Pan Q; Zheng J; Song Z; Zhang Z
    BMC Ophthalmol; 2019 Sep; 19(1):200. PubMed ID: 31519158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab (Avastin) and panretinal photocoagulation in the treatment of high-risk proliferative diabetic retinopathy.
    Yang CS; Hung KC; Huang YM; Hsu WM
    J Ocul Pharmacol Ther; 2013; 29(6):550-5. PubMed ID: 23495932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of bevacizumab for vitreous haemorrhage in proliferative diabetic retinopathy with prior complete panretinal photocoagulation.
    Park YJ; Ahn J; Kim TW; Park SJ; Joo K; Park KH; Shin JY
    Eye (Lond); 2021 Nov; 35(11):3056-3063. PubMed ID: 33420422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review and Meta-Analysis of Clinical Outcomes of Small Gauge Vitrectomy with or without Intravitreal Anti-Vascular Endothelial Growth Factor Agents Pretreatment for Proliferative Diabetic Retinopathy.
    Pei M; Zhao X; Wan G
    Ophthalmic Res; 2023; 66(1):777-790. PubMed ID: 36972566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab for surgical treatment of severe proliferative diabetic retinopathy.
    di Lauro R; De Ruggiero P; di Lauro R; di Lauro MT; Romano MR
    Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):785-91. PubMed ID: 20135139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy.
    Sato T; Morita S; Bando H; Sato S; Ikeda T; Emi K
    Middle East Afr J Ophthalmol; 2013; 20(1):51-5. PubMed ID: 23580852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.
    Park DH; Shin JP; Kim SY
    Graefes Arch Clin Exp Ophthalmol; 2010 May; 248(5):641-50. PubMed ID: 20012643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab for proliferative diabetic retinopathy with new dense vitreous hemorrhage after full panretinal photocoagulation.
    Sinawat S; Rattanapakorn T; Sanguansak T; Yospaiboon Y; Sinawat S
    Eye (Lond); 2013 Dec; 27(12):1391-6. PubMed ID: 24037235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of intravitreal injection of Ranibizumab as pre-treatment for vitrectomy in proliferative diabetic retinopathy with vitreous hemorrhage.
    Li S; Yang Y; Zou J; Zeng J; Ding C
    BMC Ophthalmol; 2022 Feb; 22(1):63. PubMed ID: 35139812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual Acuity, Vitreous Hemorrhage, and Other Ocular Outcomes After Vitrectomy vs Aflibercept for Vitreous Hemorrhage Due to Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
    Glassman AR; Beaulieu WT; Maguire MG; Antoszyk AN; Chow CC; Elman MJ; Jampol LM; Salehi-Had H; Sun JK;
    JAMA Ophthalmol; 2021 Jul; 139(7):725-733. PubMed ID: 33956075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Tamponade in Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.
    Balakrishnan D; Jain B; Nayaka A; Rani PK; Mukundaprasad V; Jalali S
    Semin Ophthalmol; 2017; 32(4):488-491. PubMed ID: 27128601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Six-month visual outcome after pars plana vitrectomy in proliferative diabetic retinopathy with or without a single preoperative injection of intravitreal bevacizumab.
    Gupta A; Bansal R; Gupta V; Dogra MR
    Int Ophthalmol; 2012 Apr; 32(2):135-44. PubMed ID: 22450558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitrectomy Due to Vitreous Hemorrhage and Tractional Retinal Detachment Secondary to Eales' Disease.
    Ersöz MG; Hocaoğlu M; Sayman Muslubaş IB; Arf S; Karaçorlu M
    Turk J Ophthalmol; 2021 Apr; 51(2):102-106. PubMed ID: 33951898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tractional Retinal Detachment in Eyes with Vitreous Hemorrhage and Proliferative Diabetic Retinopathy and Posterior Vitreous Detachment in Fellow Eye.
    Joo CW; An Y; Kim YK; Kim YD; Park SP; Kim KL
    Korean J Ophthalmol; 2023 Jun; 37(3):207-215. PubMed ID: 37068834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary: Outcomes of preoperative bevacizumab in diabetics with nonclearing vitreous hemorrhage without tractional detachment - A quasi-randomized retrospective study.
    Ahuja AA; Mishra C
    Indian J Ophthalmol; 2021 Nov; 69(11):3287-3288. PubMed ID: 34708789
    [No Abstract]   [Full Text] [Related]  

  • 17. Prophylactic intravitreal injection of aflibercept for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy: A randomized controlled trial.
    Qu J; Chen X; Liu Q; Wang F; Li M; Zhou Q; Yao J; Li X
    Front Public Health; 2022; 10():1067670. PubMed ID: 36711366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing the incidence of early postoperative vitreous haemorrhage by preoperative intravitreal bevacizumab in vitrectomy for diabetic tractional retinal detachment.
    Yeung L; Liu L; Wu WC; Kuo YH; Chao AN; Chen KJ; Yang KJ; Chen TL; Lai CC
    Acta Ophthalmol; 2010 Sep; 88(6):635-40. PubMed ID: 19432872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical outcome of full-thickness macular hole secondary to tractional retinal detachment in proliferative diabetic retinopathy.
    Babu N; Kohli P; Mishra C; Rajan RP; Kumar K; Ramasamy K; Dara R; Lakshmi CC
    Indian J Ophthalmol; 2021 Nov; 69(11):3302-3307. PubMed ID: 34708793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized clinical trial evaluating intravitreal ranibizumab or saline for vitreous hemorrhage from proliferative diabetic retinopathy.
    Diabetic Retinopathy Clinical Research Network*
    JAMA Ophthalmol; 2013 Mar; 131(3):283-93. PubMed ID: 23370902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.